
QUICK LINKS
SEE ALSO...
p53 (A-1) Antibody is an IgG1 kappa light chain mouse monoclonal antibody, also designated TP53, that detects the p53 protein of mouse, rat, and human origin by western blotting, immunoprecipitation, immunofluorescence, and enzyme-linked immunosorbent assay. p53 monoclonal antibody (A-1) is available as the non-conjugated anti-p53 antibody form, as well as multiple conjugated forms of anti-p53 antibody (A-1), including agarose, horseradish peroxidase, phycoerythrin, fluorescein isothiocyanate, and multiple Alexa Fluor® conjugates. The p53 protein, encoded by the TP53 gene in humans, is a pivotal tumor suppressor and has an important role in maintaining genomic stability. As a transcription factor, p53 regulates the expression of genes involved in essential cellular processes such as cell cycle arrest, DNA repair, apoptosis, and senescence. Upon detecting DNA damage, p53 can induce cell cycle arrest at the G1/S checkpoint, allowing time for repair before replication proceeds. If the damage is irreparable, p53 can initiate apoptosis to eliminate the potentially harmful cell, preventing the propagation of mutations. The activity of p53 is tightly regulated through post-translational modifications like phosphorylation, acetylation, and ubiquitination, which affect its stability and function. MDM2 is a key negative regulator that promotes p53 degradation via the ubiquitin-proteasome pathway. Mutations in the TP53 gene are found in approximately 50% of human cancers, making it one of the most frequently mutated genes associated with cancer. These mutations often occur in the DNA-binding domain of p53, leading to a loss of its tumor-suppressing capabilities. Some mutant forms not only lose their protective functions but also gain oncogenic properties that promote tumor development. Understanding the structural domains of p53, the transactivation domain, DNA-binding domain, and oligomerization domain, is essential as each is critical for its function. Research on p53 has significant implications for cancer therapy, with strategies aiming to restore its normal function in tumors by developing small molecules to reactivate mutant p53 or inhibit its negative regulators like MDM2. Animal models, such as p53 knockout mice, along with p53 antibodies like the p53 mouse monoclonal antibody (A-1), have been instrumental in advancing our overall understanding of the protein′s functions and importance by offering valuable insights into cellular stress responses and tumor suppression mechanisms.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
p53 Antibody (A-1) | sc-393031 | 200 µg/ml | $322.00 | |||
p53 Antibody (A-1): m-IgG1 BP-HRP Bundle | sc-531749 | 200 µg Ab; 20 µg BP | $361.00 | |||
p53 Antibody (A-1) AC | sc-393031 AC | 500 µg/ml, 25% agarose | $424.00 | |||
p53 Antibody (A-1) HRP | sc-393031 HRP | 200 µg/ml | $322.00 | |||
p53 Antibody (A-1) FITC | sc-393031 FITC | 200 µg/ml | $336.00 | |||
p53 Antibody (A-1) PE | sc-393031 PE | 200 µg/ml | $349.00 | |||
p53 Antibody (A-1) Alexa Fluor® 488 | sc-393031 AF488 | 200 µg/ml | $364.00 | |||
p53 Antibody (A-1) Alexa Fluor® 546 | sc-393031 AF546 | 200 µg/ml | $364.00 | |||
p53 Antibody (A-1) Alexa Fluor® 594 | sc-393031 AF594 | 200 µg/ml | $364.00 | |||
p53 Antibody (A-1) Alexa Fluor® 647 | sc-393031 AF647 | 200 µg/ml | $364.00 | |||
p53 Antibody (A-1) Alexa Fluor® 680 | sc-393031 AF680 | 200 µg/ml | $364.00 | |||
p53 Antibody (A-1) Alexa Fluor® 790 | sc-393031 AF790 | 200 µg/ml | $364.00 | |||
p53 Antibody (A-1) B | sc-393031 B | 200 µg/ml | $326.00 | |||
p53 (A-1) Neutralizing Peptide | sc-393031 P | 100 µg/0.5 ml | $69.00 |